ArticleAnnals of thoracic surgery short reports2026
Clinical, Quality, and Cost Outcomes of Patients With Early-Stage Non-Small Cell Lung Cancer Undergoing Surgery or Stereotactic Body Radiation Therapy.
Article in Annals of thoracic surgery short reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We evaluated how National Surgical Quality Improvement Program (NSQIP) risk, frailty, and quality of life influence treatment selection between surgery and stereotactic body radiotherapy (SBRT) in early-stage non-small cell lung cancer (NSCLC). Methods: Prospectively collected data from treatment-naive adults with early-stage NSCLC included demographics, pulmonary function, NSQIP risk scores, and frailty (index ≥3). Quality of life was assessed by Quality of Life Questionnaire Core 30, Quality of Life Questionnaire Lung Cancer 13, and modified Medical Research Council Dyspnea Scale tools. Results: SBRT was more likely for frail patients (odds ratio [OR], 4.92), those needing assistance (OR, 5.01), and those with disability (OR, 3.48) or impaired mobility (OR, 4.04). Multivariate analysis found that higher NSQIP mortality risk (OR, 12.60), frailty (OR, 4.80), and lower forced expiratory volume in 1 second predicted SBRT selection. Complications were more frequent after surgery (41% vs 17%; Conclusions: Frailty, NSQIP risk, and functional metrics help guide treatment selection in early-stage NSCLC. Surgery yields better survival and recurrence outcomes, whereas SBRT offers lower early morbidity and cost in selected patients.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.